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A. Biological Assays
Trypanosome Growth and Viability Assays: BSF 90-13 T. brucei, a 427 strain, was grown as described previously. 1, 2 To score viability, parasites (1 x 10 4 /mL BSF) were seeded into 96-well clear-bottomed polystyrene plates in 200 µl HMI-9 supplemented with 10% fetal bovine serum and 10%
Serum Plus (Sigma-Aldrich, St. Louis, MO) and grown in the presence of compound (2 µl) or equivalently diluted carrier for 3 days in 5% CO 2 at 37 o C. All assays were performed in triplicate. After incubation (72 hr, at 37 °C), CellTiter-Blue (Promega) was added and fluorescence measured (560 Ex /590 Em ).
Purification of Bacterially Expressed TbHK1 and enzyme assay:
For purification of bacterially expressed TbHK1 (rTbHK1), a starter culture of E. coli M15(pREP) harboring pQE30 (Qiagen, Valencia, CA) with the TbHK1 gene cloned in frame of a 6-His tagging sequence was grown to an OD of ~1 and then induced for 24
hr at room temperature with 0.25 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and purified as described previously. 3 HK assays were performed in triplicate as described using a coupled reaction to measure enzyme activity. 3, 4 In short, the coupled assay uses glucose-6-phosphate dehydrogenase (G6PDH) to convert glucose-6-phosphate (G6-P) generated by HK to 6-phosphogluconate with coincident reduction of NADP to NADPH, which is monitored spectrophotometrically at 340 nm. Note that EbSe was found to be ineffective in a counterscreen for inhibition of G6PDH. Kinetic analyses were performed using KaleidaGraph 4.1 (Synergy Software, Reading, PA).
S3 Live Cell imaging:
Bloodstream form (BSF) trypanosomes (427 strain 9013) harboring pXS6:PTSmCherry were incubated with 13 (20 µM) for 10 min before they were harvested by centrifugation at 800 g for 10 min. Cells were washed once in 1×PBS, collected by centrifugation, and resuspended in 1×PBS for live cell microscopy. Images were generated using an 
B. Synthesis of BABA derivatives
All reagents were purchased from commercial suppliers and used without further purification. Potassium carbonate was ground and dried in an oven overnight at 140 ˚C.
All isolated products were purified via flash column chromatography using silica gel SDS 60 C.C. 40-63 µm. 1 H and 13 C NMR spectra were collected at ambient temperature on a 300 (Bruker Avance) or 500 MHz NMR spectrometer (Bruker Avance or JEOL Eclipse). Infrared (IR) spectra, reported in cm -1 , were collected using a Fourier transform spectrophotometer. Compounds 3 7 and 9 8 were prepared using known methods and exhibited spectral data consistent with previously reported syntheses.
Synthesis of 10
S5
To a dry 100 mL round-bottomed flask was added 9 (250 mg, 0.802 mmol, 1 eq),
tert-butylcarbonylbenzeneboronic acid (214 mg, 0.962 mmol, 1.2 eq), PdCl 2 (dtbpf) (10.5 mg, 0.016 mmol, 0.02 eq), and potassium carbonate (168 mg, 1.203 mmol, 1.5 eq). The solids were then taken up in 9.5 mL acetonitrile and 0.5 mL water. The resulting solution was then refluxed for 48 hours under N 2 . The reaction mixture was cooled to room temperature and filtered through a celite plug. The celite plug was rinsed with 100 mL ethyl acetate, 100 mL dichloromethane, and 100 mL methanol. The filtrate was dried with sodium sulfate, filtered, and evaporated onto a silica gel plug doped with five pipet drops of triethylamine. Product 10 was obtained as a waxy solid in 96% yield (262 mg) after silica gel column chromatography utilizing 1% triethylamine in DCM as eluent. 
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Synthesis of 11
To a dry, 100 mL round-bottomed flask was added 4-tert-butyl benzoic acid (193 mg, 1.084 mmol, 1.1 eq) and 5 mL anhydrous DCM. Triethylamine (0.227 mL, 1.626 mmol, 1.65 eq) was added and the solution was cooled to 0 ˚C on an ice water bath.
Then thionyl chloride (1 M in DCM) (1.2 mL, 1.192 mmol, 1.21 eq) was added to the solution. The solution was stirred at 0 ˚C for 30 min., then the solvent was evaporated.
The residue was re-dissolved in 5 mL anhydrous dichloromethane and triethylamine (0.227 mL, 1.626 mmol, 1.65 eq) at 0 ˚C. To the acid chloride was then slowly added 10 (356 mg, 0.986 mmol, 1 eq) dissolved in 5 mL anhydrous DCM and triethylamine (0.227 mL, 1.626 mmol, 1.65 eq). The reaction mixture was stirred at 0 ˚C for 30 min, then the solution was refluxed under nitrogen overnight. The reaction mixture was cooled to room temperature and evaporated. The residue was taken up in 50 mL ethyl acetate, then washed with saturated sodium bicarbonate (3 x 50 mL) and saturated brine (50 mL).
The aq. layer was washed with ethyl acetate (50 mL). The combined organics were dried over sodium sulfate, filtered, and evaporated onto silica. Product 11 was obtained 
S8
To a dry 100 mL round-bottomed flask was added 11 (412mg, 0.789 mmol, 1 eq) and 8.0 mL anhydrous DCM. Trifluoroacetic acid (2.6 mL, 37.5 mmol, 44.1 equiv) was then added. The reaction mixture was stirred at room temperature overnight under N 2 .
The solvent was evaporated the following day and ice-cold diethyl ether (10 mL) was added to the mixture followed by slow evaporation on the rotary evaporator. This procedure was repeated twice more. 
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protocol, the coupling solution was ejected from the syringe and the resin was further processed as described below.
Peptide Cleavage and Isolation: The resin containing the fully assembled peptide-drug conjugate was washed with DMF (3 x 5 mL), DCM (3 x 5 mL), and methanol (3 x 5 mL).
Residual solvents were dried using suction and then the resin was further dried under vacuum (i.e. in a 25 ˚C vacuum oven) overnight. After drying, the resin was treated with Table S1 below) and 1 H NMR. Short peptides (i.e. < 8 residues) prepared using this method are typically isolated in greater than 95% purity as crude isolates.
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